- AI-screener
- Securities US
- Johnson & Johnson
Johnson & Johnson
$155.51
$1.37
0.89%
6 Jun 20:00
$140.68
$169.99
52 weeks low/high
Market sentiment
Section about market participants' moods: bulls holding long positions (“longs”) and bears holding short positions (“shorts”).
Overall assessment
bullish sentiment increases
6day with a yield of-0.12%
Long
100.00%Short
0.00%| Index | Bulls | Bears |
|---|---|---|
Confidence | — | |
Support | — | |
Cash flows | — |
Momentum
Indicators for analyzing trends in the instrument. Based on them you can choose the optimal moment to open or close a position.
Return/MDD
3.30Sentiment
BullishStart Date
05.20.2025Duration
17Yield
0.89%Avg.Yield
0.66%
Volatility
1.75%Max MDD
-0.27%Avg. MDD
-1.21%Min Price
RUB 152.43Max Price
RUB 155.40
Protective stop levels
S/L 5%RUB 147.28 | S/L 10%RUB 139.53 | S/L 15%RUB 131.78 | |
|---|---|---|---|
Day | 0.34% | 0.00% | 0.00% |
Week | 19.04% | 0.72% | 0.00% |
Month | 52.29% | 18.94% | 4.29% |
Technical analysis
- Trend ClassTurning down
- Trend PowerAlmost flat
- PatternSymmetrical triangle
- EMA-20Bullish reversal2025-05-29 the price crossed up the moving average line and getting closer to the MA, which means that the short-term upside trend weakens.
- EMA-50Bearish reversalThe price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.
- EMA-100Bearish reversal2025-05-08 the price crossed down the moving average line and getting closer to the MA, which means that the short-term downside trend weakens.
- StochasticBullish RecoveryThe stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: main and signal line crossing.
- RSIBearishRSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.
- MACDBullish reversalOscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: main and signal line crossing.
- Candle pattern typeHanged ManIs a candlestick that consists of a small body near the high with a little or no upper shadow and a long lower tail. Considered to be a bearish pattern during an uptrend.Date of signal:
Prices and risks
Price
| Change | Change by industry | Min. | Max. | Volume | |
|---|---|---|---|---|---|
| Yesterday | -0.57% | 2.64% | $154.00 | $156.03 | 598.17M |
| Week | -0.69% | 3.10% | $152.30 | $156.03 | 4.58B |
| Month | -2.01% | 0.45% | $146.12 | $157.94 | 17.08B |
| 3 Months | -7.52% | 0.82% | $141.50 | $169.90 | 50.19B |
| 6 Months | 3.28% | 16.34% | $140.68 | $169.99 | 92.78B |
| Year | 4.79% | 0.64% | $140.68 | $169.99 | 153.26B |
| 3 years | -13.55% | 75.95% | $140.68 | $183.35 | 524.59B |
| 5 years | 4.68% | 100.06% | $133.65 | $186.69 | 859.64B |
| All time | 207.41% | 81.24% | $46.25 | $186.69 | 843.88B |
Volatility
| JNJ | By industry | |
|---|---|---|
| Yesterday | 16.23% | 1.28% |
| Week | 1.35% | 7.29% |
| Month | 2.81% | 10.86% |
| 3 Months | 8.39% | 20.88% |
| 6 Months | 10.47% | 29.79% |
| Year | 18.94% | 39.37% |
| 3 years | 29.80% | 85.40% |
| 5 years | 37.79% | 115.71% |
| All time | — | — |
- Sortino
- 0.16
- Sharpe
- 0.20
- Sterling
- 0.25
- Liquidity index
- 7.59
- Alpha
- -0.00041
- Beta
- 0.34
AI Factors
Drivers of growth or decline are external factors, selected using AI, that can significantly affect the price of a company's shares in the future.
Fundamental analysis
Indicators for the last quarter and their dynamics for 5 quarters
Ratios
Valuation
Debts
Efficiency
Other ratios
Revenue
Financials
Growth
Assets
Debts
News
About
$373.01B
Capitalization
2.41B
Shares outstanding
Health Care
Sector
Pharmaceuticals
Industry
US4781601046
ISIN
100
Lot size
Mr. Joaquin Duato
CEO
Website
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.